Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. GLP-1

GLP-1

  • Diabetes (799)
    • Blood Glucose Meters (4)
    • Complications (179)
    • Diabetes in Pregnancy (14)
    • Diabetes Meds (72)
    • Drug-Induced Hypo/Hyperglycemia (134)
    • Monitoring (128)
    • Natural Medicines/Supplements (14)
    • Prevention (56)
    • Treatment (342)
      • Alpha-Glucosidase Inhibitors (28)
      • Amylin Agonist (14)
      • Bromocriptine (7)
      • Combination Products (19)
      • Gliptins (77)
      • Glitazones (115)
      • GLP-1 (42)
      • Incretin Enhancers/Mimetics (68)
      • Insulin (174)
      • Meglitinides (41)
      • Metformin (155)
      • SGLT2 Inhibitors (84)
      • Sulfonylureas (110)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (13)
  • Hyperglycemia (29)
  • Hypoglycemia (29)
  • Other (28)
  • Prediabetes (5)
  • Resources (222)
  • Thyroid Disorders (57)
1 - 15 of 42 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: How to Switch Insulin Products February 2025
Chart: Comparison of Insulins (Canada) January 2025
Chart: Diabetes Medications: Cardiovascular and Kidney Impact January 2025
Chart: Drugs for Type 2 Diabetes December 2024
Chart: Comparison of GLP-1 and GIP/GLP-1 Receptor Agonists
August 2024
Chart: Guide for Helping Patients Afford Their Medications
March 2024
Article: Navigate Common Hurdles With GLP-1 Agonists February 2024
Article: Clarify the Role of Tirzepatide for Type 2 Diabetes January 2024
Toolbox: Improving Diabetes Outcomes February 2023
Article: Watch for Gallbladder Problems in Patients on GLP-1 Agonists November 2022
Technician Tutorial: Dispensing Insulin and Other Injectable Diabetes Meds August 2022
Article: Consider Cardiovascular Benefits When Recommending a GLP-1 Agonist August 2019
Chart: Comparison of GLP-1 Agonists August 2019
Article: Individualize Type 2 Diabetes Regimens for Older Adults July 2019
Article: Weigh Pros and Cons of SGLT2 Inhibitors for Kidney Protection June 2019
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved